BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25141107)

  • 1. Cross-sectional study comparing different therapeutic modalities for cystic lymphangiomas in children.
    Olímpio Hde O; Bustorff-Silva J; Oliveira Filho AG; Araujo KC
    Clinics (Sao Paulo); 2014 Aug; 69(8):505-8. PubMed ID: 25141107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OK-432 therapy for lymphangiomas.
    Smith RJ; Burke DK; Sato Y; Poust RI; Kimura K; Bauman NM
    Arch Otolaryngol Head Neck Surg; 1996 Nov; 122(11):1195-9. PubMed ID: 8906054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OK-432 therapy for cervical lymphangioma.
    Sichel JY; Udassin R; Gozal D; Koplewitz BZ; Dano I; Eliashar R
    Laryngoscope; 2004 Oct; 114(10):1805-9. PubMed ID: 15454776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous sclerotherapy of massive macrocystic lymphatic malformations of the face and neck using fibrin glue with OK-432 and bleomycin.
    Chen WL; Huang ZQ; Chai Q; Zhang DM; Wang YY; Wang HJ; Wang L; Fan S
    Int J Oral Maxillofac Surg; 2011 Jun; 40(6):572-6. PubMed ID: 21367582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bleomycin therapy for cystic hygroma.
    Orford J; Barker A; Thonell S; King P; Murphy J
    J Pediatr Surg; 1995 Sep; 30(9):1282-7. PubMed ID: 8523225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New treatment for cystic lymphangiomas of the face and neck: cyst wall rupture and cyst aspiration combined with sclerotherapy.
    Mitsukawa N; Satoh K
    J Craniofac Surg; 2012 Jul; 23(4):1117-9. PubMed ID: 22777463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OK-432: an effective sclerosing agent for the treatment of lymphangiomas of head and neck.
    Baskota DK; Singh BB; Sinha BK
    Kathmandu Univ Med J (KUMJ); 2007; 5(3):312-7. PubMed ID: 18604046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OK-432 sclerotherapy in head and neck lymphangiomas: long-term follow-up result.
    Yoo JC; Ahn Y; Lim YS; Hah JH; Kwon TK; Sung MW; Kim KH
    Otolaryngol Head Neck Surg; 2009 Jan; 140(1):120-3. PubMed ID: 19130974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of lymphangiomas in children: an update of Picibanil (OK-432) sclerotherapy.
    Greinwald JH; Burke DK; Sato Y; Poust RI; Kimura K; Bauman NM; Smith RJ
    Otolaryngol Head Neck Surg; 1999 Oct; 121(4):381-7. PubMed ID: 10504592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sclerosing of recurrent lymphangioma using OK-432.
    Mikhail M; Kennedy R; Cramer B; Smith T
    J Pediatr Surg; 1995 Aug; 30(8):1159-60. PubMed ID: 7472972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sclerotherapy of lymphangiomas of the head and neck.
    Wiegand S; Eivazi B; Zimmermann AP; Sesterhenn AM; Werner JA
    Head Neck; 2011 Nov; 33(11):1649-55. PubMed ID: 20737487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of lymphangiomas arising around cervico-facial region: surgery, bleomycin therapy and OK-432 therapy].
    Ogita S; Tsuto T; Deguchi E; Tokiwa K; Yanagihara J; Iwai N
    Nihon Geka Gakkai Zasshi; 1989 Sep; 90(9):1389-91. PubMed ID: 2479816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of lymphangioma in children: our experience of 128 cases.
    Okazaki T; Iwatani S; Yanai T; Kobayashi H; Kato Y; Marusasa T; Lane GJ; Yamataka A
    J Pediatr Surg; 2007 Feb; 42(2):386-9. PubMed ID: 17270554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of cystic hygroma in children with special reference to OK-432 therapy.
    Ogita S; Tsuto T; Tokiwa K; Takahashi T
    Z Kinderchir; 1987 Oct; 42(5):279-81. PubMed ID: 2446443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of lymphangiomas with OK-432 (Picibanil) sclerotherapy: a prospective multi-institutional trial.
    Giguère CM; Bauman NM; Sato Y; Burke DK; Greinwald JH; Pransky S; Kelley P; Georgeson K; Smith RJ
    Arch Otolaryngol Head Neck Surg; 2002 Oct; 128(10):1137-44. PubMed ID: 12365884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intralesional bleomycin and sodium tetradecyl sulphate for haemangiomas and lymphangiomas.
    Harjai MM; Jha M
    Afr J Paediatr Surg; 2012; 9(1):47-51. PubMed ID: 22382104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sclerotherapy for lymphangioma in children.
    Sanlialp I; Karnak I; Tanyel FC; Senocak ME; Büyükpamukçu N
    Int J Pediatr Otorhinolaryngol; 2003 Jul; 67(7):795-800. PubMed ID: 12791456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OK-432 therapy of lymphangiomas in children.
    Schmidt B; Schimpl G; Höllwarth ME
    Eur J Pediatr; 1996 Aug; 155(8):649-52. PubMed ID: 8839717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of lymphangiomas with OK-432 (Picibanil).
    Rautio R; Keski-Nisula L; Laranne J; Laasonen E
    Cardiovasc Intervent Radiol; 2003; 26(1):31-6. PubMed ID: 12491020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bleomycin sclerotherapy in congenital lymphatic and vascular malformations of head and neck.
    Mathur NN; Rana I; Bothra R; Dhawan R; Kathuria G; Pradhan T
    Int J Pediatr Otorhinolaryngol; 2005 Jan; 69(1):75-80. PubMed ID: 15627451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.